Tenet Healthcare (NYSE:THC) hit a new 52-week high Tuesday as it is currently trading at $49.16, above its previous 52-week high of $49.13 with 113,082 shares traded as of 10:06 a.m. ET. Average volume has been two million shares over the past 30 days.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- Tenet Healthcare (NYSE: THC) hit a new 52-week high Tuesday as it is currently trading at $49.16, above its previous 52-week high of $49.13 with 113,082 shares traded as of 10:06 a.m. ET. Average volume has been two million shares over the past 30 days. Tenet Healthcare has a market cap of $5.04 billion and is part of the health care sector and health services industry. Shares are up 49.9% year to date as of the close of trading on Monday. Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. The company has a P/E ratio of 139, above the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. You can view the full Tenet Healthcare Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.